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Background: Despite long-term or permanent health problems, cancer survivors are often motivated to return to
work. For cancer survivors who have lost their job, return to work can be more challenging compared to employed
survivors, as they generally find themselves in a more vulnerable social and financial position. Cancer survivors with
job loss may therefore be in need of tailored return to work support. However, there is a lack of return to work
intervention programs specifically targeting these cancer survivors. The number of cancer survivors with job loss in
developed countries is rising due to, amongst others, increases in the incidence and survivor rate of cancer, the
retirement age and the proportion of flexible employment contracts. Hence, we consider it important to develop
a tailored return to work intervention program for cancer survivors with job loss, and to evaluate its effectiveness
compared to usual care.
Methods/Design: This study employs a two-armed randomised controlled trial with a follow-up period of
12 months. The study population (n = 164) will be recruited from a national sample of cancer survivors (18–60
years), who have been sick-listed for 12–36 months. Participants will be randomised by using computerized
blocked randomisation (blocks of four). All participants will receive usual care as provided by the Dutch Social
Security Agency. Additionally, participants in the intervention group will receive a tailored return to work
intervention program, which includes vocational rehabilitation and supportive psychosocial components, as
well as (therapeutic) placement at work. The primary outcome measure is duration until sustainable return to
work; the secondary outcome measure is rate of return to work. Other parameters include, amongst others,
fatigue, coping strategy and quality of life. We will perform Cox regression analyses to estimate hazard ratios for
time to sustainable return to work.
Discussion: The hypothesis of this study is that a tailored approach for cancer survivors with job loss is more
effective, regarding return to work, compared to usual care. The results of this study will provide insight into
the ways in which return to work can be facilitated for cancer survivors with job loss.
Trial registration: Netherlands Trial Register: NTR3562.
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Cancer is increasingly perceived as a chronic disease
with long-term or permanent health problems [1-3].
Multiple studies report cancer survivors (CSs) to experi-
ence, for example, fatigue, depression or functional im-
pairments long after treatment has been completed
[4-6]. As a result, CSs’ quality of life, daily functioning
and labour participation may be affected [7,8]. With re-
gard to labour market participation, studies have shown
that CSs are often motivated to return to work (RTW)
and that they attribute positive effects to work. That is,
CSs have reported that work enables them to regain a
sense of normalty and control [9]. Also, RTW reduces
avoidable work disability, thereby decreasing the risk of
financial loss for both CSs and society [10].
A recent review found that circa 62% of CSs return to
work within 12 months of sick leave. Although the ma-
jority of CSs eventually returns to work, still a consider-
able group of CSs does not resume work. Multiple
reasons have been reported for CSs not returning to
work, most of which can be categorized as cancer-
related, psychosocial-related or work-related [11]. Specif-
ically, work-related factors, such as absence of an em-
ployment contract, may create barriers for RTW of CSs.
For persons with an insecure employment status, in gen-
eral, the literature clearly shows that they experience a
larger (emotional and practical) distance to the labour
market, are lower educated and have an increased risk
for prolonged sick leave compared to employees [12,13].
Also, in their RTW, CSs with job loss may face unique
barriers, such as having to go through job application
processes and compete with “healthy” workers for a job.
As a result, after cancer, the RTW process for persons
with job loss may be different from the RTW process in
employed persons.
In the absence of an employer, CSs who have lost their
job in the Netherlands may receive sickness or disability
benefits from the Dutch Social Security Agency (SSA). If
so, they will be supported by a SSA team, which consists
of an insurance physician, a reintegration expert and a
labour expert. The number of CSs that receive benefits,
either temporary or permanent, has increased over the
years. For instance, in 2013, 10.2% more CSs were re-
ceiving temporary disability benefits and 17.7% more
CSs were receiving permanent disability benefits, com-
pared to 2012 [14]. It is expected that the number of
CSs with job loss in the occupational age will keep
rising, not only in the Netherlands, but also in other
Western economy countries, as a result of the increases
in the incidence and survival rate of cancer [15], the re-
tirement age [16], and the proportion of flexible employ-
ment contracts [17]. The Dutch SSA has specifically
expressed a need for a tailored RTW intervention pro-
gram for this target group. Current RTW programs areusually aimed at adjusting the current workplace of the
CS and negotiating with the CS’s own employer. For CSs
with job loss, these programs are not suitable, as they
have no workplace or employer (anymore). In addition,
it is important to consider that, for CSs with job loss,
RTW includes job application processes and starting
in a new job that comes with an unfamiliar working
environment. Consequently, CSs with job loss are in
need of tailored support that targets these specific bar-
riers to RTW.
Therefore, the aim of this study is to develop a tailored
RTW intervention program for CSs with job loss, and to
study its effectiveness on duration until sustainable
RTW in a randomised controlled trial with a follow-up
period of 12 months, compared to usual care, as cur-
rently provided by the SSA.
Methods/Design
Design/setting
This study employs a two-armed non-blinded rando-
mised controlled trial (RCT) with a follow-up period of
12 months. Data will be gathered using questionnaires at
baseline, 3, 6 and 12 months post-study entry. Prior to
the start of this study, a focus group study with CSs with
job loss and/or unemployment experience was con-
ducted, in order to explore barriers and facilitators they
experienced with regard to RTW. We used the results
from this focus group study to develop the intervention
program that is being evaluated in this study. Design
and results of the focus group study will be published
separately. The CONSORT statement was used to report
the design of this study [18]. The study was approved by
the Medical Ethical Committee of the VU University
Medical Center (VUmc) and the Scientific Committee of
the EMGO+ Institute / VUmc.
Study population
The study population consists of CSs with job loss, aged
18 to 60 years, who are registered at the SSA and who
have been sick-listed and receiving sickness or disability
benefits in the last 12–36 months. Within the group of
CSs with job loss, registered at the SSA, three subtypes
of workers can be distinguished: (1) workers whose
temporary employment contract ended before or during
sick leave; (2) temporary agency workers, and (3) un-
employed workers, i.e., these workers had lost their job
prior to their cancer diagnosis, and consequently, they
received unemployment benefits. After being diagnosed
with cancer, their benefits changed from unemployment
benefits to sickness or disability benefits.
CSs who have lost their job will be included in this
study if they have completed intensive cancer treatment
(at least) six weeks prior to the start of this study (based
on self-report by the CS), if their health status allows
Figure 1 Participant recruitment flow diagram.
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the CS) and if they have no comorbidities (e.g., severe
psychological or physical conditions, apart from a poten-
tial cancer diagnosis) that would interfere with partici-
pating in this study (based on report from the CSs’
general practitioner (GP)). In case a CS is invited to
participate, but is still receiving, or scheduled to receive,
intensive (cancer) treatment (e.g., chemotherapy, radio-
therapy, surgery or another type of intensive curative
treatment), he/she will be wait-listed for inclusion until
(at least) six weeks after completing such treatment(s).
Furthermore, CSs will be excluded in case of pregnancy,
lack of knowledge of the Dutch language and/or an on-
going conflict with the SSA regarding a sickness or dis-
ability benefit claim. Additionally, CSs will be excluded if
they are participating, or signed up to be a participant,
in a concurrent scientific study and/or re-integration or
rehabilitation program aimed at RTW.
Recruitment of participants
The process of recruitment is described below and illus-
trated in the participant recruitment flow diagram
(Figure 1).
Potentially eligible participants will be recruited using
the national database of the SSA, in which persons ap-
plying for sickness or disability benefits are registered.
The database contains data regarding demographics,
employment status, type of sickness or disability benefit
and medical cause, due to which the benefits are
granted. A search query will be developed to identify
CSs with granted benefits due to a cancer diagnosis. An
in-house SSA researcher will use the query to identify
potential participants, because of privacy concerns. This
SSA researcher will only be involved in this particular
part of the recruitment process and in no other parts of
the study. Retrospectively, the search query will be used
only once to identify CSs who have been sick-listed from
12 to 36 months. Prospectively, with a frequency of twice
per month, the search query will be used to identify CSs
who have been sick-listed for 12 months. Prospective re-
cruitment will continue for an estimated duration of one
and a half years, until the sample size will be reached.
Potential participants will receive an information pack-
age from the SSA, which will contain an invitational let-
ter from the chief medical officer from the SSA, a
brochure with more detailed information on the study,
an informed consent form in which respondents can
give their consent to be contacted for information re-
garding the study, and a short questionnaire. The infor-
mation package will also include a postcard, by which
persons can respond to the researcher whether they are
interested in the study or they can provide for declining
participation, in case they wish not to participate. Also,
on the postcard they can select the option of receivingonly the baseline questionnaire, which aims to collect
data for comparison between responders and non-
responders. Finally, if a person is willing to participate,
but only after a few weeks or months, they can select
‘contact me later’ on the postcard. Potential participants
who do not return either the short questionnaire, includ-
ing informed consent form, or the postcard, will receive
a reminder letter after two weeks.
The short questionnaire in the information package
aims to indicate whether or not the respondent is eli-
gible for participation. Only when a respondent is clearly
not eligible for participation in the study, based on
this short questionnaire, the researchers will send an
informational letter to thank them for their interest in
the study. All other respondents will be contacted by
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study procedures and to check if they meet the criteria
for participation in the study. After the telephone call,
respondents who meet the criteria will receive the
baseline questionnaire and a second informed consent
form, in which respondents give their consent to par-
ticipate in the study. Respondents will be offered a
choice between receiving the baseline and follow-up
questionnaires on paper or via e-mail. If they do not
return the baseline questionnaire and/or the informed
consent form, then a reminder letter or e-mail will be
send after two weeks. When the respondent returns
the baseline questionnaire and the informed consent
form, he/she will be included in the study and ran-
domly allocated to either the intervention group or
the control group. The participant’s GP and the team
at the SSA will be notified of the inclusion of the par-
ticipant in this study and they will receive information
about the study. The participant’s file at the SSA will
be labelled as ‘research participant’ to facilitate easy
recognition by the SSA experts. The GP will be asked
to report if the participant has any comorbidities that
would interfere with participation (in the intervention
program) in this study. In case the participant’s GP
feels that a participant’s medical case may be unsuit-
able for participation in the study, the GP can contact
the researchers to deliberate. If necessary, the re-
searchers will organize a joint meeting with the GP
and the research team to discuss the CS’s case and
achieve consensus about participation.
All participants will be guided by their SSA team ac-
cording to usual care. Additionally, participants in the
intervention group will receive the tailored RTW inter-
vention program. All participants will be asked to
complete all questionnaires prior to randomisation (T0),
at 3 months (T1), at 6 months (T2) and at 12 months
(T3) post-study entry. If a person does not return a
follow-up questionnaire, then a reminder letter or e-mail
will be sent after two weeks.
Tailored RTW intervention program
The intervention program was developed as a tailored
RTW program in which participants, together with a
RTW coach, will decide which needs should be ad-
dressed for the participant to RTW. The program was
developed by the researchers in cooperation with the
Dutch SSA and a national re-integration agency. In the
developmental process of the program, we took results
from previous studies on RTW for CSs into account
[19-21]. For example, this tailored RTW intervention
program contains a multidisciplinary approach towards
RTW, as the literature showed that multidisciplinary
RTW interventions for CSs may be more effective com-
pared to monodisciplinary interventions or usual care[20,21]. Furthermore, we obtained advice from import-
ant stakeholders in the field of ‘cancer and work’ in the
Netherlands, i.e., medical specialists in oncology, medical
social workers, re-integration and vocational rehabilita-
tion agencies, and the Dutch Cancer Patient Movement
(Leven met Kanker Beweging) [22]. Finally, we con-
ducted a focus group study with CSs with job loss and
with insurance physicians, to identify barriers and facili-
tators for RTW specifically in CSs with job loss. For ex-
ample, we discussed which barriers and facilitators CSs
with job loss experience in their RTW after cancer. Also,
we explored what a suitable duration and intensity level,
in terms of frequency of appointments, would be for the
intervention program, and in what way the intervention
program and the study procedures could be imple-
mented at the SSA. We used the results of the focus
group study in the developmental process of the inter-
vention program.
The intervention is consistent with the ‘Dutch Guide-
line of Oncologic Revalidation (Richtlijn Oncologische
Revalidatie)’ [23] and includes elements of a participa-
tory approach, in which the participant will be actively
involved in the development, content and execution of
his/her RTW plan. Specifically, the participant will be
encouraged to actively participate in (1) developing his/
her consensus-based tailored RTW plan, (2) coaching on
identifying obstacles and creating possibilities for RTW,
and (3) exploring possibilities for (therapeutic) return to
an actual workplace. The first two steps (developing a
RTW plan and coaching) will take place in the partici-
pant’s home or at a location nearby, and will be carried
out by a re-integration agency, specialized in coaching
and support of CSs regarding RTW. The third step
(actual placement in a workplace) will be carried out by
two job hunting agencies and the participants will travel
to the nearest local office(s) of the agencies. The content
of the tailored RTW intervention program is, to a
certain extent, related to the attitudes-social influences-
efficacy model [24]. That is, the first part of the interven-
tion program, i.e., preparation for RTW, relates to
behavioral determinants such as attitude and (self-)
efficacy. The latter part of the program, e.g., removing
barriers for RTW, relates to social influence by in-
volvement of facilitating professionals in the RTW
process.
Content of the intervention program
The tailored RTW intervention program will start with
an introductory interview between the participant and
an assigned coach from the re-integration agency. Prior
to the introductory interview, the participant will be
asked to fill out an additional introductory question-
naire. This questionnaire is specifically designed for the
coach to obtain insight in the participant’s motivation
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ical and/or psycho-educational), and the skills and
knowledge of the participant regarding work and job ap-
plication processes (e.g., the skill to write letters of appli-
cation). The results of this questionnaire will be used as
input for an introductory interview and to construct a
work profile for the participant. During the interview,
obstacles and possibilities for RTW and other forms of
activities will be identified. Also, the coach and partici-
pant will work together during the interview to tailor
the participant’s intervention program. There will be
several options (or ‘routes’) to tailor the intervention.
The possible routes are displayed in Figure 2.
Routes in the intervention program
First, the coach will decide, together with the partici-
pant, whether or not the participant is ready to RTW,
or needs additional support and preparation in order
to RTW.
Route 1
The participant is ready to RTW at the time of the intro-
ductory interview. The coach will contact the re-
searchers to independently assign a job hunting agency
to this participant. The job hunter will invite the partici-
pant for a meeting to explore job opportunities, thereby
taking the participant’s work profile into account. Job
hunters will always explicitly ask for a participant’s per-
mission to inform future employers of the participants’
history of cancer. Based on the work profile, the job
hunter will start a search for at least two jobs, fitting the
profile. These jobs should be for at least three months
and may include (1) working in paid employment, or (2)
working in temporary employment, i.e., this type of work
can be arranged with therapeutic conditions and on-
going benefits. The job hunter will have to find jobs
within four weeks after the meeting with the participant.
If the job hunter is unable to find these jobs, then the
second job hunting agency involved in this study will
also be invited to search for jobs for the participant. This
involvement includes transfer of confidential informationFigure 2 Routes in the tailored RTW intervention program.about the participant. The participant will be informed
thoroughly about this procedure. Also, the participant can
use the established work profile to look for jobs independ-
ently, alongside the job search with the job hunter. The
total search time for a job will be three months. If both
job hunting agencies do not find a suitable job for the par-
ticipant by then, or if the participant is not able to RTW,
then the intervention program will end. The participant
will still receive usual care by the SSA during the entire
follow-up period.
If the job hunter finds a suitable job, the job hunter
will stay in touch with the participant during the
remaining period (up to three months) of the interven-
tion program, to monitor whether the participant’s RTW
is successful and satisfactory. If applicable, the partici-
pant can continue to work in the new job after the inter-
vention program has been completed.Route 2
The participant needs support and preparation to
RTW. The coach and participant can explore several
topics for coaching. After the introductory interview,
the participant will receive four sessions of coaching
on chosen themes, e.g., how to deal with fatigue or
changed life priorities, how to combine work and fam-
ily, et cetera. As the intervention program continues,
the coach and participant will gradually develop a
work profile, which will incorporate the participant’s
capabilities, needs and preferences for a workplace.
After completing the work profile, the coach and par-
ticipant will decide whether or not the participant is
ready to RTW (Route 2A or Route 2B).Route 2A
The participant is ready to RTW. The participant will
continue as described in Route 1. If the participant
needs support at the workplace, the participant may re-
ceive five additional sessions of coaching while being in
the process of RTW.
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The participant needs more preparation to RTW. The
participant will receive five additional sessions of coach-
ing on chosen themes. After this, the coach and partici-
pant will again decide whether or not the participant is
ready to RTW (Route 3A or Route 3B).
Route 3A
If the participant is ready to RTW, the participant will
continue as described in Route 1.
Route 3B
If the participant is not ready to RTW, the intervention
program will be terminated.
In Route 2, both 2A and 2B, the coach can also opt for
additional support, for example support from a physical
therapist and/or psychologist, in case specific physical
and/or mental problems are present. If this is the case,
the coach will discuss this with the participant’s expert
team at the SSA and/or the participant’s GP.
Completion of the intervention program
The total duration of the program in the most extensive
route (2B followed by 3A) will be six to seven months.
Here, the participants will receive preparation to RTW
for a maximum of four months, including ten sessions
of coaching, job application preparation and possibly re-
covery support, such as physical therapy, and placement
in a workplace for a minimum of three months. In gen-
eral, we anticipate that duration of the program will vary
between participants. Some participants will need the
most extensive route, and others may need less support
in order to facilitate their RTW. Also, in case of extraor-
dinary circumstances, participants can put their tailored
RTW intervention program on hold for a period of one
month maximum. The limit of one month was chosen
to allow for the program to be tailored to each partici-
pant’s needs, while maintaining a relatively similar dur-
ation of most participants’ programs. We will monitor
the chosen route(s) for each participant. During the pro-
gram, members of the SSA team, as well as the GP, will
be notified of the program’s start, progress and finish.
They will receive a copy of the intervention plan and the
evaluation report.
Outcome measures & prognostic factors
Data regarding primary and secondary outcome mea-
sures, as well as prognostic factors such as sociodemo-
graphic factors (i.e., age, gender, level of education),
disease-related and work-related factors will be collected
using questionnaires. If possible, additional data regard-
ing usual care will be collected from the participant’s file
at the SSA. The primary outcome measure of this study
is duration until sustainable RTW after sick leave,calculated as the number of days between the day of
randomisation and the first day of sustainable RTW.
Sustainable RTW is defined as a period of minimum 28
calendar days, during which the CS is working according
to schedule. Work can be either paid work or work re-
sumption with ongoing benefits, e.g., work with thera-
peutic conditions. Recurrences of sick leave within four
weeks of RTW will be considered as belonging to the
initial period of sick leave, in accordance with the re-
quirements of the Dutch Sickness Benefits legislation.
The secondary outcome measure of this study is rate of
RTW, i.e., the proportion of participants in each group
that sustainably returns to work. Rate of RTW will be
not only obtained from questionnaire data, but also, if
possible, from participants’ files at the SSA. We will
collect data on a number of prognostic factors:
– Intention to RTW will be measured using
the ‘Attitudes-Social influence-self-Efficacy’
questionnaire (ASE) [25]. This questionnaire
was designed to assess intention to RTW
in a study of unemployed persons with common
mental disorders. The questionnaire has not
been validated. Therefore, its results will be
used as an indicator for intention to RTW;
– Readiness to RTW will be measured using the
Readiness to RTW Scale (RRTW) [26]. The items
on the scale are related to the five stages of
change described in the Transtheoretical model by
Prochaska and DiClemente [27]. We will adjust the
Scale to the Dutch situation as there is no validated
translation available, and use the results of this
scale as an indicator of readiness to RTW, instead
of a validated outcome measure;
– Fatigue will be assessed with the 13-item self-
reported FACT-Fatigue Scale (Version 4) [28].
Fatigue is measured in this questionnaire on a
four-point scale (range 0–52). It has a high
internal validity with a Cronbach’s alpha of 0.96
and high test-retest reliability (ICC = 0.95) [29];
– Psychological distress will be assessed with the
Centre for Epidemiological Studies Depression
Scale (CES-D) [30-32]. The CES-D is a 20-items
questionnaire, measured on a four-point scale.
It is designed to measure depressive symptomatol-
ogy in the general population and has a high reli-
ability with a Cronbach’s alpha of 0.79-0.92 and a
test-retest score of 0.90;
– General participation in society will be measured
using the Utrecht Scale for Evaluation of Revalidation
and Participation (User-P) [33]. The User-P scale
aims to rate objective and subjective participation in
persons with physical disabilities and consists of 31
items in three scales: Frequency, Restrictions, and
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USER-Participation scales is moderate to good,
with Cronbach’s alpha ranging between 0.70 and
0.91. Spearman correlations between these scales
range between 0.36 and 0.52. Test-retest reliabil-
ity of the User-P scales was measured using the
intraclass correlation coefficient (ICC). The ICC
of the USER-P was 0.65 for the Frequency scale,
0.85 for the Restrictions scale, and 0.84 for the
Satisfaction scale;
– Coping will be measured using the Utrecht Coping
List (UCL) [34]. The UCL has 47 statements
covering seven coping strategies, such as active
problem solving, seeking social support and depressive
reaction, and is scored on a four-point scale. Its reli-
ability varies between 0.43 and 0.89, depending on the
subscale used. The test-retest score ranges from 0.45
to 0.85, depending on the subscale used;
– General health and quality of life will be assessed
with the European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire
(EORTC QLQ C-30 version 3.0) [35]. This 30-item
list incorporates nine multi-item scales: five
functional scales (physical, role, cognitive,
emotional and social); three symptom scales
(fatigue, pain, nausea and vomiting); and a global
health and quality of life scale. The test-retest
score has shown to be high for all functional
scales with a range of 0.82 to 0.91, and a reliabil-
ity score over 0.80 for four out of five scales, with
cognitive functioning scoring 0.68 [36];
– Health-related quality of life will be measured
using the EuroQol 5D scale, developed by the
EuroQol group (EQ-5D) [37]. The EQ-5D consists
of 5 scales: Mobility, Self-care, Usual activity, Pain/
Discomfort, and Anxiety/Depression, with a scale of
three levels per item (i.e., no problem, some prob-
lems, and extreme problems). The EQ-5D is a gen-
eric instrument and has been used in cancer
research in numerous studies. Furthermore, a visual
analogue scale is provided (range 0–100) to assess
overall health state;
– Limitations experienced at work will be measured
in participants who have returned to work during
the follow-up period, using the Work Limitations
Questionnaire (WLQ) [38]. The WLQ consists of
25 items, which describe four dimensions of limita-
tions: limitations in handling time, physical, mental
and interpersonal limitations. The questionnaire
was tested in two field trials, and the four scales
achieved Cronbach’s alphas of > 0.90.
– Occupational impact of sleep will be measured in
participants who have returned to work during the
follow-up period, using the Dutch OccupationalImpact of Sleep Questionnaire (OISQ) [39]. The
OISQ consists of 24 items, which aim to assess
the effect of sleep quality on work performance.
The OISQ has been validated in the Dutch population,
correlating highly with other validated sleep
questionnaires (coefficients range 0.28 to 0.43,
P < 0.0001) and has a high reliability score
(Cronbach’s alpha of 0.96). This measure was
added as studies have demonstrated that sleep
disturbances are common in CSs and that they
are related to poorer physical and emotional
health, concentration problems (for example at
work), and difficulty coping with stress [40].
Process evaluation
A process evaluation will be conducted to examine the
tailored RTW intervention program regarding feasibility,
satisfaction, and barriers and facilitators for implementa-
tion. The process evaluation will be designed according
to the RE-AIM (Reach, Effectiveness, Adoption, Im-
plementation, and Maintenance) framework [41]. The
measurements of the process evaluation will be based
on: (1) data regarding study procedures and adherence
to study protocol, and (2) data collected using add-
itional process evaluation questionnaires, which will
be designed separately for participants, team members
from the SSA, the re-integration agency and the job
hunting agencies.
Sample size
As a starting point for calculating the sample size, we
chose a Hazard Ratio of 2, indicating that the partici-
pants in the intervention group RTW twice as quickly
compared to the participants in the control group. This
Hazard Ratio is based on comparable studies on RTW of
workers who are sick-listed and who are receiving sick-
ness benefits [42,43]. Assuming that half of the workers
will achieve sustainable RTW during the first 12 months
of the follow-up period, and based on a power of (1-β=)
0.80 and a two-sided significance level of 0.05 (α), a sam-
ple size of 130 participants (n = 2 × 65) is needed. Based
on comparable research, loss to follow-up of 20% is
taken into account. This results in 164 participants
(n = 2 × 82) to be included in the study. This number of
participants seems feasible as samples from the registra-
tion database at the SSA indicate that approximately
3000 persons could be invited for participation over a
time period of one and a half year.
Randomisation
Prior to randomisation, we will apply pre-stratification
in our inclusion procedure to ensure equal representa-
tion of the three subtypes amongst CSs with job loss in
our sample; (1) workers whose temporary employment
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agency workers; and (3) unemployed workers. Random-
isation to either the intervention group or control group
will be performed on the individual level and will be per-
formed separately for each stratum. Randomisation will
be performed by the coordinating researchers (with the
exception of the executive researcher), using computer-
ized blocked randomisation by means of the Randomisa-
tion Plan Generator [44]. The number of participants in
each block will be four, with an allocation ratio of 1:1.
Blinding to the randomisation outcome in this study is
not possible due to the nature of the intervention pro-
gram, in which various stakeholders will need to cooper-
ate to support and guide participants in the intervention
group. Furthermore, for practical reasons with regard to
usual care, the researchers will have to inform the SSA
team and the GP of participants about the inclusion of
the participant and the group to which the participant
was randomised.Co-interventions and compliance
For participants in the control group, we cannot prevent
co-interventions, e.g., recovery therapy or support from
job hunters, being offered to them, as these interven-
tions can be part of the SSA’s usual care. For participants
in the intervention group, we will ask the SSA team not
to offer any additional interventions during the period in
which the CS participates in our intervention program.
During the follow-up period, after the intervention pro-
gram in this study has been completed, the SSA team
may still offer interventions that are available through
usual care. We will monitor any co-interventions offered
in both groups by asking questions about this in the
questionnaires and, if possible, by data from the partici-
pants’ files at the SSA.Statistical analysis
All statistical analyses will be performed according to
the intension-to-treat principle. If necessary, the per-
protocol principle will also be applied [45]. Descriptive
analyses will be performed to check whether there are
relevant differences in the baseline characteristics of the
intervention and the control group at baseline. Analyses
will be performed on an individual level. All analyses will
be performed both crude and adjusted for potential
confounders, e.g., gender, age, stratum of participants, or
type of cancer. Also, these variables will be checked for
effect modification. Scores on the included outcomes
measures and parameters in the study will be calculated
according to published scoring algorithms. The results
of the questionnaires will be compared between both
groups at baseline and at 3, 6 and 12 months follow-up.
Correction for baseline values will be applied.The primary outcome measure, duration until sus-
tainable RTW in both groups, will be described using
the Kaplan-Meier method. We will use the Cox pro-
portional hazard model to estimate hazard ratios and
corresponding 95% confidence intervals for sustain-
able RTW. Finally, we will also perform multiple re-
gression analysis to determine associations between
the primary outcome measure and predictor variables,
such as fatigue and coping strategy, in order to iden-
tify prognostic factors for RTW in this population. A
two-tailed significance level of <0.05 is considered sta-
tistically significant in all analyses. All analyses will be
performed using SPSS 20.0 [46].
Discussion
In light of an increasing incidence of cancer and an im-
proving survival rate [47], a rising retirement age [16,48]
and a growing number of temporary employment con-
tracts within Western labour markets [17], it is expected
that the number of CSs have who lost their job in the
working age will increase. CSs with job loss may experi-
ence unique challenges in their RTW process, compared
to employed CSs, e.g., competition with “healthy” indi-
viduals for a job, lack of a workplace to return to and
lack of social support from colleagues or an employer.
Therefore, they may be in need for a tailored approach
for RTW. This study aims to evaluate the effectiveness
of a tailored RTW intervention program on duration
until sustainable RTW of CSs with job loss, compared to
usual care.
Methodological considerations regarding the study design
There are several methodological aspects of this study
that can be considered. One of the main strengths of this
study is that, in the developmental process of the tai-
lored RTW intervention program, we have incorporated
(1) ideas and perspectives of a large variety of stake-
holders in the fields of cancer, work and insurance medi-
cine in the Netherlands, (2) results from previous
international studies on RTW for CSs, and (3) results
from a qualitative focus group study on barriers and
facilitators for RTW in CSs with job loss. Another
strength of this study is that we will evaluate the effect-
iveness of the tailored RTW intervention program with
a RCT design, and that we will conduct a process evalu-
ation alongside the RCT. Furthermore, the procedures
for this study were developed in accordance with the
Dutch SSA. This will facilitate implementation of the
study protocol, particularly the recruitment protocol, at
the SSA.
There are also several limitations to be considered
with regard to the study design. First of all, this is the
first study to be conducted that incorporates a RTW
intervention for CSs with job loss. Therefore, in
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we had to rely on indirect evidence from studies on
RTW for employed CSs, and adjust this information,
taking into account our knowledge of the situation of
CSs with job loss, which is a subjective process. We
did not take other intervention studies on RTW in
persons with chronic diseases (other than cancer) into
account in developing the tailored RTW intervention
program. Still, the tailored RTW intervention program
is based on elements of the attitudes-social influences-
efficacy model [24], which indicates that there is, to
some extent, a scientific basis for the content of the
program.
Ideally, this study design would have incorporated a
pilot phase, in which we could evaluate whether the
intervention program would be acceptable and suffi-
ciently tailored to the needs of CSs with job loss. In
addition, a pilot study would have enabled us to discover
potential implementation problems for the intervention
program beforehand and to evaluate whether or not the
chosen recruitment strategy for the RCT would be feas-
ible and successful. Unfortunately, we were not able to
carry out a pilot phase in this study.
With regard to the sample size, we chose a Hazard
Ratio of 2, which is not uncommon for studies in
(moderately) comparable populations. Still, this number
might be optimistic in terms of the anticipated results.
Another limitation is that this study does not use
blinding, i.e., we have to disclose to the participant’s
RTW team at the SSA whether the participant is in the
intervention group or the control group. This could
potentially lead to awareness in the SSA teams about
their care being evaluated, which could result in a differ-
ent type of usual care provided to the intervention group
compared to the control group. Finally, blinding could
prevent contamination of the control group, but as this
study recruits 82 participants for the intervention group
on a national level, the researchers estimate the risk of
contamination of the control group marginal. Potentially,
increased awareness of RTW could lead to participants in
the control group employing RTW activities on their own,
which they might not have done if they were not partici-
pating in the study. Enhanced RTW activities in the con-
trol group could distort a potential effect of the tailored
RTW intervention program and lead to an underestima-
tion of any effect that will be measured between the inter-
vention group and the control group. Finally, it is not
unlikely that CSs with job loss feel disappointed in the
labour market (due to job loss) or the social security sys-
tem (due to a lack of appropriate RTW interventions),
which may influence their willingness to participate in an
experimental study that offers a RTW intervention pro-
gram. This could potentially lead to selection bias in our
sample of participants.Implications of study findings for research
The results of this study will contribute to the literature
by providing insight into the RTW process of CSs with
job loss and the ways in which RTW can be facilitated
for them. In a broader perspective, the results of this
study may change the way the RTW process of CSs is
generally studied. To this day, the literature on RTW
does not distinguish CSs based on work-related factors,
such as working status or type of employment contract,
but rather distinguishes CSs on medical factors, such as
type of diagnosis. If the results of this study demonstrate
a positive effect in favor of a tailored approach for CSs
with job loss, then opportunities may be created to de-
velop future RTW interventions tailored to work-related
factors, e.g., employment status, present in CSs. Possibly,
this approach may also be applied to persons with job
loss with other (chronic) conditions, in order to facilitate
their RTW.
Implications of study findings for practice
This study may demonstrate that it is effective to tailor
RTW support for CSs to work-related factors, such as
employment status, at least in Western economy coun-
tries. If so, policymakers should find ways to implement
tailored RTW intervention programs for CSs with job
loss. This study may also have a positive impact on the
increasing burden of sickness and disability benefits. As
more CSs may return to work as a result of a tailored
RTW intervention program, the number of CSs receiv-
ing benefits will decrease. As benefits are indirectly pro-
vided by the tax payers in Western economy countries,
society as a whole could potentially profit from a higher
number of CSs returning to work.
Conclusion
There is a gap in the literature regarding the RTW
process of CSs who have lost their job. We hypothesize
that CSs with job loss benefit from a tailored approach
regarding RTW support, as a result of unique challenges,
e.g., lack of a current job, going through job application
processes, competing with “healthy” individuals for a job
and having a large emotional and practical distance to
the labour market. This study aims to facilitate sustain-
able RTW for CSs with job loss, by offering a tailored
RTW intervention program and evaluate its effectiveness
compared to usual care. Results of this study will be
available in 2016.
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